Belpointe Asset Management LLC Thermo Fisher Scientific Inc. Transaction History

Belpointe Asset Management LLC

  • $1.28 Billion
  • Q2 2024

A detailed history of Belpointe Asset Management LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Belpointe Asset Management LLC holds 6,265 shares of TMO stock, worth $3.84 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
6,265
Previous 6,374 1.71%
Holding current value
$3.84 Million
Previous $3.7 Million 6.48%
% of portfolio
0.27%
Previous 0.3%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024
SELL
$541.52 - $599.02 $59,025 - $65,293
-109 Reduced 1.71%
6,265 $3.46 Million
Q1 2024

May 08, 2024
BUY
$528.82 - $599.43 $186,144 - $210,999
352 Added 5.85%
6,374 $3.7 Million
Q4 2023

Feb 13, 2024
BUY
$431.41 - $532.94 $606,993 - $749,846
1,407 Added 30.49%
6,022 $3.2 Million
Q3 2023

Nov 15, 2023
BUY
$498.29 - $574.41 $6,477 - $7,467
13 Added 0.28%
4,615 $2.34 Million
Q2 2023

Aug 14, 2023
SELL
$508.46 - $591.13 $911,160 - $1.06 Million
-1,792 Reduced 28.03%
4,602 $2.4 Million
Q1 2023

May 15, 2023
BUY
$535.0 - $604.82 $127,330 - $143,947
238 Added 3.87%
6,394 $3.69 Million
Q4 2022

Feb 08, 2023
BUY
$484.71 - $571.37 $190,975 - $225,119
394 Added 6.84%
6,156 $3.39 Million
Q3 2022

Nov 14, 2022
BUY
$507.19 - $604.49 $279,968 - $333,678
552 Added 10.6%
5,762 $2.92 Million
Q2 2022

Aug 02, 2022
SELL
$500.9 - $612.21 $553,494 - $676,492
-1,105 Reduced 17.5%
5,210 $2.83 Million
Q1 2022

Apr 28, 2022
SELL
$524.0 - $644.92 $278,768 - $343,097
-532 Reduced 7.77%
6,315 $3.73 Million
Q4 2021

Feb 15, 2022
SELL
$569.0 - $667.24 $200,288 - $234,868
-352 Reduced 4.89%
6,847 $4.57 Million
Q3 2021

Nov 15, 2021
BUY
$509.53 - $609.78 $942,630 - $1.13 Million
1,850 Added 34.59%
7,199 $4.11 Million
Q2 2021

Aug 09, 2021
BUY
$441.0 - $508.24 $388,080 - $447,251
880 Added 19.69%
5,349 $2.7 Million
Q1 2021

May 14, 2021
SELL
$439.85 - $518.83 $592,917 - $699,382
-1,348 Reduced 23.17%
4,469 $2.04 Million
Q4 2020

Feb 16, 2021
BUY
$435.06 - $527.66 $157,056 - $190,485
361 Added 6.62%
5,817 $2.71 Million
Q3 2020

Nov 13, 2020
BUY
$359.77 - $441.52 $343,580 - $421,651
955 Added 21.22%
5,456 $2.41 Million
Q3 2020

Nov 13, 2020
BUY
$359.77 - $441.52 $48,209 - $59,163
134 Added 3.07%
4,501 $1.28 Million
Q2 2020

Jul 20, 2020
SELL
$275.2 - $362.34 $36,876 - $48,553
-134 Reduced 2.98%
4,367 $1.58 Million
Q1 2020

Jul 20, 2020
SELL
$255.3 - $340.05 $53,357 - $71,070
-209 Reduced 4.44%
4,501 $1.28 Million
Q4 2019

Feb 18, 2020
BUY
$271.93 - $328.04 $783,702 - $945,411
2,882 Added 157.66%
4,710 $1.53 Million
Q3 2019

Jan 16, 2020
BUY
$268.46 - $305.43 $70,873 - $80,633
264 Added 16.88%
1,828 $533,000
Q2 2019

Nov 22, 2019
SELL
$257.51 - $295.55 $688,066 - $789,709
-2,672 Reduced 63.08%
1,564 $0
Q1 2019

Jun 11, 2019
BUY
$212.17 - $273.72 $581,345 - $749,992
2,740 Added 183.16%
4,236 $1.16 Million
Q4 2018

Mar 06, 2019
SELL
$208.47 - $251.98 $239,740 - $289,777
-1,150 Reduced 43.46%
1,496 $335,000
Q3 2018

Nov 23, 2018
SELL
$205.57 - $244.32 $57,354 - $68,165
-279 Reduced 9.54%
2,646 $646,000
Q2 2018

Aug 06, 2018
BUY
$203.14 - $219.53 $594,184 - $642,125
2,925 New
2,925 $606,000
Q1 2018

Aug 06, 2018
SELL
$192.98 - $224.11 $378,819 - $439,927
-1,963 Closed
0 $0
Q4 2017

Feb 15, 2018
BUY
$182.03 - $200.37 $89,558 - $98,582
492 Added 33.45%
1,963 $373,000
Q3 2017

Nov 16, 2017
BUY
$171.74 - $194.04 $252,629 - $285,432
1,471
1,471 $278,000

Others Institutions Holding TMO

# of Institutions
2,779
Shares Held
340M
Call Options Held
1.42M
Put Options Held
2.15M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $240B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email